share_log

Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know

Benzinga ·  May 22 14:00

Throughout the last three months, 5 analysts have evaluated Abbott Laboratories (NYSE:ABT), offering a diverse set of opinions from bullish to bearish.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings23000
Last 30D10000
1M Ago01000
2M Ago12000
3M Ago00000

Insights from analysts' 12-month price targets are revealed, presenting an average target of $127.4, a high estimate of $140.00, and a low estimate of $119.00. A decline of 0.93% from the prior average price target is evident in the current average.

price target chart

Deciphering Analyst Ratings: An In-Depth Analysis

A...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment